The results suggest that IL4I1 is a tumor-produced metabolic enzyme that mainly catabolizes tryptophan to activate AHR, enhancing tumor aggressiveness and inhibiting anti-tumor immunity [151, 152]. This evidence concerns the gene IL4I1 and neoplasm.